380 related articles for article (PubMed ID: 27037060)
21. [Analysis of the characteristics of side population cells in the human ovarian cancer cell line OVCAR-3].
Luo LJ; Zhao Z; Zeng JF; Liang B; Yang JX; Cao DY; Shen K
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):281-5. PubMed ID: 22781115
[TBL] [Abstract][Full Text] [Related]
22. Partially purified components of Nardostachys chinensis suppress melanin synthesis through ERK and Akt signaling pathway with cAMP down-regulation in B16F10 cells.
Jang JY; Kim HN; Kim YR; Choi WY; Choi YH; Shin HK; Choi BT
J Ethnopharmacol; 2011 Oct; 137(3):1207-14. PubMed ID: 21816215
[TBL] [Abstract][Full Text] [Related]
23. High Novel Oncogene with Kinase-Domain (NOK) Gene Expression is Associated with the Progression of Renal Cell Carcinoma.
Cao Q; Chen M; Li Z; Huang W; Jin Y; Ye X; Tong M
Clin Lab; 2016; 62(1-2):179-86. PubMed ID: 27012048
[TBL] [Abstract][Full Text] [Related]
24. Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction.
Huang JS; Yao CJ; Chuang SE; Yeh CT; Lee LM; Chen RM; Chao WJ; Whang-Peng J; Lai GM
BMC Cancer; 2016 Mar; 16():245. PubMed ID: 27012679
[TBL] [Abstract][Full Text] [Related]
25. Regulation of expression of ABCB1 and LRP genes by mitogen-activated protein kinase/extracellular signal-regulated kinase pathway and its role in generation of side population cells in canine lymphoma cell lines.
Tomiyasu H; Watanabe M; Goto-Koshino Y; Fujino Y; Ohno K; Sugano S; Tsujimoto H
Leuk Lymphoma; 2013 Jun; 54(6):1309-15. PubMed ID: 23167606
[TBL] [Abstract][Full Text] [Related]
26. Caveolin-1 in renal cell carcinoma promotes tumour cell invasion, and in co-operation with pERK predicts metastases in patients with clinically confined disease.
Campbell L; Al-Jayyoussi G; Gutteridge R; Gumbleton N; Griffiths R; Gumbleton S; Smith MW; Griffiths DF; Gumbleton M
J Transl Med; 2013 Oct; 11():255. PubMed ID: 24119769
[TBL] [Abstract][Full Text] [Related]
27. The PTEN/PI3K/Akt pathway regulates stem-like cells in primary esophageal carcinoma cells.
Li H; Gao Q; Guo L; Lu SH
Cancer Biol Ther; 2011 Jun; 11(11):950-8. PubMed ID: 21467840
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway.
Chang YL; Zhou PJ; Wei L; Li W; Ji Z; Fang YX; Gao WQ
Oncotarget; 2015 Sep; 6(27):24017-31. PubMed ID: 26172296
[TBL] [Abstract][Full Text] [Related]
29. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
[TBL] [Abstract][Full Text] [Related]
30. Protein kinase C regulates human pluripotent stem cell self-renewal.
Kinehara M; Kawamura S; Tateyama D; Suga M; Matsumura H; Mimura S; Hirayama N; Hirata M; Uchio-Yamada K; Kohara A; Yanagihara K; Furue MK
PLoS One; 2013; 8(1):e54122. PubMed ID: 23349801
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of the PI3K/AKT and MAPK/ERK pathways involved in the maintenance of self-renewal in lung cancer stem-like cells.
Li J; Wang J; Xie D; Pei Q; Wan X; Xing HR; Ye T
Int J Biol Sci; 2021; 17(5):1191-1202. PubMed ID: 33867839
[TBL] [Abstract][Full Text] [Related]
32. The therapeutic value of SC66 in human renal cell carcinoma cells.
Xu M; Wang Y; Zhou LN; Xu LJ; Jin ZC; Yang DR; Chen MB; Zhu J
Cell Death Dis; 2020 May; 11(5):353. PubMed ID: 32393791
[TBL] [Abstract][Full Text] [Related]
33. Impact of PKCε downregulation on autophagy in glioblastoma cells.
Toton E; Romaniuk A; Konieczna N; Hofmann J; Barciszewski J; Rybczynska M
BMC Cancer; 2018 Feb; 18(1):185. PubMed ID: 29439667
[TBL] [Abstract][Full Text] [Related]
34. Acetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and Stat3 signaling, thus suppressing chemoresistant stem cell-like properties.
Liu YQ; Wang SK; Xu QQ; Yuan HQ; Guo YX; Wang Q; Kong F; Lin ZM; Sun DQ; Wang RM; Lou HX
Acta Pharmacol Sin; 2019 May; 40(5):689-698. PubMed ID: 30171201
[TBL] [Abstract][Full Text] [Related]
35. SIRT3 inhibits prostate cancer by destabilizing oncoprotein c-MYC through regulation of the PI3K/Akt pathway.
Quan Y; Wang N; Chen Q; Xu J; Cheng W; Di M; Xia W; Gao WQ
Oncotarget; 2015 Sep; 6(28):26494-507. PubMed ID: 26317998
[TBL] [Abstract][Full Text] [Related]
36. Grb2-associated binder 2 silencing impairs growth and migration of H1975 cells via modulation of PI3K-Akt signaling.
Wang WJ; Mou K; Wu XF; Zhang JZ; Ren G; Qi JD; Xu YF; Yao X
Int J Clin Exp Pathol; 2015; 8(9):10575-84. PubMed ID: 26617767
[TBL] [Abstract][Full Text] [Related]
37. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
Wang L; Park P; La Marca F; Than KD; Lin CY
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
[TBL] [Abstract][Full Text] [Related]
38. PI 3 kinase-dependent Akt kinase and PKCepsilon independently regulate interferon-gamma-induced STAT1alpha serine phosphorylation to induce monocyte chemotactic protein-1 expression.
Venkatesan BA; Mahimainathan L; Ghosh-Choudhury N; Gorin Y; Bhandari B; Valente AJ; Abboud HE; Choudhury GG
Cell Signal; 2006 Apr; 18(4):508-18. PubMed ID: 16157472
[TBL] [Abstract][Full Text] [Related]
39. Triptonide acts as a novel potent anti-lymphoma agent with low toxicity mainly through inhibition of proto-oncogene Lyn transcription and suppression of Lyn signal pathway.
Yang P; Dong F; Zhou Q
Toxicol Lett; 2017 Aug; 278():9-17. PubMed ID: 28666825
[TBL] [Abstract][Full Text] [Related]
40. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer.
Aziz MH; Manoharan HT; Church DR; Dreckschmidt NE; Zhong W; Oberley TD; Wilding G; Verma AK
Cancer Res; 2007 Sep; 67(18):8828-38. PubMed ID: 17875724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
